β-Cryptoxanthin uptake in THP-1 macrophages upregulates the CYP27A1 signaling pathway

Molecular Nutrition and Food Research

Volumn 58, Issue 3, 2014, Pages 425-436

  Fu, Hongfei ^a   Wu, Canjie ^b   Riaz, Hasan ^b   Zhang, Hualin ^b   Han, Li ^b   Bai, Liya ^c   Yang, Feifei ^b   Yang, Liguo ^b  

^a NORTHWEST A F UNIVERSITY   (China)

^b HUAZHONG AGRICULTURAL UNIVERSITY   (China)

^c SHANDONG PEANUT RESEARCH INSTITUTE   (China)

Author keywords

Cryptoxanthin; Atherogensis; Mitochondrial sterol 27 hydroxylase; Retinoic acid receptor; Signaling pathway

Indexed keywords

27-HYDROXYCHOLESTEROL; CHOLESTANETRIOL 26 MONOOXYGENASE; CHOLESTEROL DERIVATIVE; CRYPTOXANTHIN; CYP27A1 PROTEIN, HUMAN; DIBENZAZEPINE DERIVATIVE; LE 540; RETINOIC ACID BINDING PROTEIN II, CELLULAR; RETINOIC ACID RECEPTOR; RETINOID;

ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LIPID METABOLISM; MACROPHAGE; METABOLISM; SIGNAL TRANSDUCTION; UPREGULATION;

CHOLESTANETRIOL 26-MONOOXYGENASE; CRYPTOXANTHINS; DIBENZAZEPINES; GENE EXPRESSION REGULATION; HUMANS; HYDROXYCHOLESTEROLS; LIPID METABOLISM; MACROPHAGES; RECEPTORS, RETINOIC ACID; RETINOIDS; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84897666632     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300329     Document Type: Article

References (82)

1. Omenn, G. S., Chemoprevention of lung cancer: the rise and demise of beta-carotene. Annu. Rev. Public Health 1998, 19, 73-99.
2. Crews, H., Alink, G., Anderson, R., Braesco, V. et al., A critical assessment of some biomarker approaches linked with dietary intake. Br. J. Nutr. 2001, 86, 5-35.
3. Stahl, W., Sies, H., Lycopene: a biologically important carotenoid for humans? Arch. Biochem. Biophys. 1996, 336, 1-9.
4. Bauernfeind, J. C., Carotenoids as Colorants and Vitamin A Precursors. Technological and Nutritional Applications, Academic Press, Inc., New York, 1981.
5. Gross, J., Pigments in Vegetables: Chlorophylls and Carotenoids, Van Nostrand Reinhold, New York, 1991.
6. Yeum, K.-J., Booth, S., Sadowski, J., Liu, C. et al., Human plasma carotenoid response to the ingestion of controlled diets high in fruits and vegetables. Am. J. Clin. Nutr. 1996, 64, 594-602.
7. Lian, F., Hu, K. Q., Russell, R. M., Wang, X. D., β-Cryptoxanthin suppresses the growth of immortalized human bronchial epithelial cells and non-small-cell lung cancer cells and up-regulates retinoic acid receptor β expression. Int. J. Cancer 2006, 119, 2084-2089.
8. Wu, C., Han, L., Riaz, H., Wang, S. et al., The chemopreventive effect of β-cryptoxanthin from mandarin on human stomach cells (BGC-823). Food Chem. 2013, 136, 1122-1129.
9. Gallicchio, L., Boyd, K., Matanoski, G., Tao, X. G. et al., Carotenoids and the risk of developing lung cancer: a systematic review. Am. J. Clin. Nutr. 2008, 88, 372-383.
10. Männistö, S., Smith-Warner, S. A., Spiegelman, D., Albanes, D. et al., Dietary carotenoids and risk of lung cancer in a pooled analysis of seven cohort studies. Cancer Epidemiol. Biomarkers Prev. 2004, 13, 40-48.
11. Steevens, J., Schouten, L. J., Goldbohm, R. A., van den Brandt, P. A., Vegetables and fruits consumption and risk of esophageal and gastric cancer subtypes in the Netherlands cohort study. Int. J. Cancer 2011, 129, 2681-2693.
12. Fu, H., Xie, B., Fan, G., Ma, S. et al., Effect of esterification with fatty acid of β-cryptoxanthin on its thermal stability and antioxidant activity by chemiluminescence method. Food Chem. 2010, 122, 602-609.
13. Miller, N. J., Sampson, J., Candeias, L. P., Bramley, P. M., Rice-Evans, C. A., Antioxidant activities of carotenes and xanthophylls. FEBS Lett. 1996, 384, 240-242.
14. Stahl, W., Junghans, A., de Boer, B., Driomina, E. S. et al., Carotenoid mixtures protect multilamellar liposomes against oxidative damage: synergistic effects of lycopene and lutein. FEBS Lett. 1998, 427, 305-308.
15. Murakami, A., Nakashima, M., Koshiba, T., Maoka, T. et al., Modifying effects of carotenoids on superoxide and nitric oxide generation from stimulated leukocytes. Cancer Lett. 2000, 149, 115-123.
16. Matsumoto, A., Mizukami, H., Mizuno, S., Umegaki, K. et al., [beta]-Cryptoxanthin, a novel natural RAR ligand, induces ATP-binding cassette transporters in macrophages. Biochem. Pharmacol. 2007, 74, 256-264.
17. Showalter, H., Defreitas, Z., Mortensen, L., Method of improving cardiovascular health. WIPO Patent. 2007, Application PCT/US2007/026055.
18. Nakamura, M., Sugiura, M., Aoki, N., High β-carotene and β-cryptoxanthin are associated with low pulse wave velocity. Atherosclerosis 2006, 184, 363-369.
19. Shirakura, Y., Takayanagi, K., Mukai, K., Tanabe, H., Inoie, M., β-Cryptoxanthin suppresses the adipogenesis of 3T3-L1 cells via RAR activation. J. Nutr. Sci. Vitaminol. 2011, 57, 426-431.
20. Takayanagi, K., Prevention of adiposity by the oral administration of β-cryptoxanthin. Front. Neurol. 2011, 2, 67-73.
21. Takayanagi, K., Morimoto, S.-i., Shirakura, Y., Mukai, K. et al., Mechanism of visceral fat reduction in Tsumura Suzuki obese, diabetes (TSOD) mice orally administered β-cryptoxanthin from Satsuma mandarin oranges (Citrus unshiu Marc). J. Agric. Food Chem. 2011, 59, 12342-12351.
22. Russell, D. W., The enzymes, regulation, and genetics of bile acid synthesis. Annu. Rev. Biochem. 2003, 72, 137-174.
23. Chiang, J., Regulation of bile acid synthesis. Front. Biosci. 1998, 3, d176-d193.
24. Björkhem, I., Andersson, O., Diczfalusy, U., Sevastik, B. et al., Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages. Proc. Natl. Acad. Sci. USA 1994, 91, 8592-8596.
25. Epstein, F. H., Ross, R., Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 1999, 340, 115-126.
26. Moghadasian, M. H., Salen, G., Frohlich, J. J., Scudamore, C. H., Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations. Arch. Neurol. 2002, 59, 527-529.
27. Cali, J. J., Hsieh, C., Francke, U., Russell, D. W., Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J. Biol. Chem. 1991, 266, 7779-7783.
28. Cali, J. J., Russell, D. W., Characterization of human sterol 27-hydroxylase. A mitochondrial cytochrome P-450 that catalyzes multiple oxidation reaction in bile acid biosynthesis. J. Biol. Chem. 1991, 266, 7774-7778.
29. Babiker, A., Andersson, O., Lund, E., Xiu, R.-J. et al., Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism. Comparison with high density lipoprotein-mediated reverse cholesterol transport. J. Biol. Chem. 1997, 272, 26253-26261.
30. Repa, J., Turley, S., Lobaccaro, J., Medina, J. et al., Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Sci. Signal. 2000, 289, 1524-1529.
31. Tontonoz, P., Mangelsdorf, D. J., Liver X receptor signaling pathways in cardiovascular disease. Mol. Endocrinol. 2003, 17, 985-993.
32. Venkateswaran, A., Laffitte, B. A., Joseph, S. B., Mak, P. A. et al., Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRα. Proc. Natl. Acad. Sci. USA 2000, 97, 12097-12102.
33. Fu, X., Menke, J. G., Chen, Y., Zhou, G. et al., 27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J. Biol. Chem. 2001, 276, 38378-38387.
34. Lund, E. G., Menke, J. G., Sparrow, C. P., Liver X receptor agonists as potential therapeutic agents for dyslipidemia and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2003, 23, 1169-1177.
35. Quinn, C. M., Jessup, W., Wong, J., Kritharides, L., Brown, A. J., Expression and regulation of sterol 27-hydroxylase (CYP27A1) in human macrophages: a role for RXR and PPARγ ligands. Biochem. J. 2005, 385, 823-830.
36. Szanto, A., Benko, S., Szatmari, I., Balint, B. L. et al., Transcriptional regulation of human CYP27 integrates retinoid, peroxisome proliferator-activated receptor, and liver X receptor signaling in macrophages. Mol. Cell. Biol. 2004, 24, 8154-8166.
37. Langmann, T., Liebisch, G., Moehle, C., Schifferer, R. et al., Gene expression profiling identifies retinoids as potent inducers of macrophage lipid efflux. Biochim. Biophys. Acta 2005, 1740, 155-161.
38. Sporn, M. B., Roberts, A. B., Goodman, D. S., The Retinoids: Biology, Chemistry, and Medicine, Raven Press, New York 1994.
39. Newcomer, M. E., Retinoid-binding proteins: structural determinants important for function. FASEB J. 1995, 9, 229-239.
40. Folli, C., Calderone, V., Ottonello, S., Bolchi, A. et al., Identification, retinoid binding, and x-ray analysis of a human retinol-binding protein. Proc. Natl. Acad. Sci. USA 2001, 98, 3710-3715.
41. Chambon, P., The nuclear receptor superfamily: a personal retrospect on the first two decades. Mol. Endocrinol. 2005, 19, 1418-1428.
42. Tall, A. R., LaLanne, F., Costet, P., Retinoid-based methods for altering macrophage cholesterol. U.S. Patent 2005, Application US 11/128, 918.
43. Palozza, P., Simone, R., Catalano, A., Parrone, N. et al., Lycopene regulation of cholesterol synthesis and efflux in human macrophages. J. Nutr. Biochem. 2011, 22, 971-978.
44. Zhang, X., Zhang, H., Tan, R., Peng, J. et al., Mechanism of earthquake simulation as a prenatal stressor retarding rat offspring development and chinese medicine correcting the retardation: hormones and gene-expression alteration. Evid. Based Complement. Alternat. Med. 2012, 670362.
45. Livak, K. J., Schmittgen, T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2-[Delta][Delta] CT method. Methods 2001, 25, 402-408.
46. Cai, K., Hua, G., Ahmad, S., Liang, A. et al., Action mechanism of inhibin α-subunit on the development of Sertoli cells and first wave of spermatogenesis in mice. PLoS One 2011, 6, e25585.
47. Babiker, A., Andersson, O., Lindblom, D., van der Linden, J. et al., Elimination of cholesterol as cholestenoic acid in human lung by sterol 27-hydroxylase: evidence that most of this steroid in the circulation is of pulmonary origin. J. Lipid Res. 1999, 40, 1417-1425.
48. Costet, P., Lalanne, F., Gerbod-Giannone, M. C., Molina, J. R. et al., Retinoic acid receptor-mediated induction of ABCA1 in macrophages. Mol. Cell. Biol. 2003, 23, 7756-7766.
49. Umemiya, H., Fukasawa, H., Ebisawa, M., Eyrolles, L. et al., Regulation of retinoidal actions by diazepinylbenzoic acids. 1 Retinoid synergists which activate the RXR-RAR heterodimers. J. Med. Chem. 1997, 40, 4222-4234.
50. Napoli, J. L., Interactions of retinoid binding proteins and enzymes in retinoid metabolism. Biochim. Biophys. Acta 1999, 1440, 139-162.
51. Ong, D. E., Newcomer, M. E., Chytil, F., Cellular retinoid-binding proteins. The Retinoids: Biology, Chemistry and Medicine, Raven Press, New York, 1994, pp. 283-317.
52. Gaub, M.-P., Lutz, Y., Ghyselinck, N. B., Scheuer, I. et al., Nuclear detection of cellular retinoic acid binding proteins I and II with new antibodies. J. Histochem. Cytochem. 1998, 46, 1103-1111.
53. Napoli, J. L., Retinoic acid homeostasis, in: Blomhoff, R. (Ed.), Vitamin A in Health and Disease, Marcel Dekker, New York 1994, pp. 135-185.
54. Napoli, J., Retinoic acid biosynthesis and metabolism. FASEB J. 1996, 10, 993-1001.
55. Boylan, J. F., Gudas, L. J., Overexpression of the cellular retinoic acid binding protein-I (CRABP-I) results in a reduction in differentiation-specific gene expression in F9 teratocarcinoma cells. J. Cell Biol. 1991, 112, 965-979.
56. Boylan, J., Gudas, L., The level of CRABP-I expression influences the amounts and types of all-trans-retinoic acid metabolites in F9 teratocarcinoma stem cells. J. Biol. Chem. 1992, 267, 21486-21491.
57. Vaezeslami, S., Mathes, E., Vasileiou, C., Borhan, B., Geiger, J. H., The structure of apo-wild-type cellular retinoic acid binding protein II at 1.4 Å and its relationship to ligand binding and nuclear translocation. J. Mol. Biol. 2006, 363, 687-701.
58. Iribarren, C., Folsom, A. R., Jacobs Jr, D. R., Gross, M. D. et al., Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis: a case-control study. Arterioscler. Thromb. Vasc. Biol. 1997, 17, 1171-1177.
59. Theodosiou, M., Laudet, V., Schubert, M., From carrot to clinic: an overview of the retinoic acid signaling pathway. Cell. Mol. Life Sci. 2010, 67, 1423-1445.
60. Kawaguchi, R., Yu, J., Honda, J., Hu, J. et al., A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A. Sci. Signal. 2007, 315, 820-825.
61. Moore, A. C., Gugger, E. T., Erdman, J. W., Brush border membrane vessels vesicles from rats and gerbils can be utilized to evaluate the intestinal uptake of all-trans and 9-cis β-carotene. J. Nutr. 1996, 126, 2904-2912.
62. Parker, R. S., Absorption, metabolism, and transport of carotenoids. FASEB J. 1996, 10, 542-551.
63. Franssen-van Hal, N. L., Bunschoten, J. E., Venema, D. P., Hollman, P. C. et al., Human intestinal and lung cell lines exposed to β-carotene show a large variation in intracellular levels of β-carotene and its metabolites. Arch. Biochem. Biophys. 2005, 439, 32-41.
64. Reboul, E., Abou, L., Mikail, C., Ghiringhelli, O. et al., Lutein transport by Caco-2 TC-7 cells occurs partly by a facilitated process involving the scavenger receptor class B type I (SR-BI). Biochem. J. 2005, 387, 455-461.
65. Delva, L., Bastie, J.-N., Rochette-Egly, C., Kraïba, R. et al., Physical and functional interactions between cellular retinoic acid binding protein II and the retinoic acid-dependent nuclear complex. Mol. Cell. Biol. 1999, 19, 7158-7167.
66. Dong, D., Ruuska, S. E., Levinthal, D. J., Noy, N., Distinct roles for cellular retinoic acid-binding proteins I and II in regulating signaling by retinoic acid. J. Biol. Chem. 1999, 274, 23695-23698.
67. Norlin, M., Wikvall, K., Enzymes in the conversion of cholesterol into bile acids. Curr. Mol. Med. 2007, 7, 199-218.
68. Björkhem, I., Do oxysterols control cholesterol homeostasis? J. Clin. Invest. 2002, 110, 725-730.
69. Russell, D. W., Oxysterol biosynthetic enzymes. Biochim. Biophys. Acta 2000, 1529, 126-135.
70. Ayaori, M., Yakushiji, E., Ogura, M., Nakaya, K. et al., Retinoic acid receptor agonists regulate expression of ATP-binding cassette transporter G1 in macrophages. Biochim. Biophys. Acta 2012, 1821, 561-572.
71. Laffitte, B. A., Repa, J. J., Joseph, S. B., Wilpitz, D. C. et al., LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc. Natl. Acad. Sci. USA 2001, 98, 507-512.
72. Soprano, D. R., Qin, P., Soprano, K. J., Retinoic acid receptors and cancers. Annu. Rev. Nutr. 2004, 24, 201-221.
73. Kim, Y.-S., Oh, D.-K., Substrate specificity of a recombinant chicken β-carotene 15, 15'-monooxygenase that converts β-carotene into retinal. Biotechnol. Lett. 2009, 31, 403-408.
74. Li, T., Chen, W., Chiang, J. Y. L., PXR induces CYP27A1 and regulates cholesterol metabolism in the intestine. J. Lipid Res. 2007, 48, 373-384.
75. Rühl, R., Induction of PXR-mediated metabolism by β-carotene. Biochim. Biophys. Acta 2005, 1740, 162-169.
76. Idres, N., Marill, J., Flexor, M. A., Chabot, G. G., Activation of retinoic acid receptor-dependent transcription by all-trans-retinoic acid metabolites and isomers. J. Biol. Chem. 2002, 277, 31491-31498.
77. Catharine Ross, A., Zolfaghari, R., Cytochrome P450s in the regulation of cellular retinoic acid metabolism. Annu. Rev. Nutr. 2011, 31, 65-87.
78. White, J. A., Guo, Y.-D., Baetz, K., Beckett-Jones, B. et al., Identification of the retinoic acid-inducible all-trans-retinoic acid 4-hydroxylase. J. Biol. Chem. 1996, 271, 29922-29927.
79. Thatcher, J. E., Isoherranen, N., The role of CYP26 enzymes in retinoic acid clearance. 2009, 5, 875-886.
80. Sowell, A., Huff, D., Yeager, P., Caudill, S., Gunter, E., Retinol, alpha-tocopherol, lutein/zeaxanthin, beta-cryptoxanthin, lycopene, alpha-carotene, trans-beta-carotene, and four retinyl esters in serum determined simultaneously by reversed-phase HPLC with multiwavelength detection. Clin. Chem. 1994, 40, 411-416.
81. Riso, P., Visioli, F., Gardana, C., Grande, S. et al., Effects of blood orange juice intake on antioxidant bioavailability and on different markers related to oxidative stress. J. Agric. Food Chem. 2005, 53, 941-947.
82. Wingerath, T., Stahl, W., Sies, H., β-Cryptoxanthin selectively increases in human chylomicrons upon ingestion of tangerine concentrate rich in β-cryptoxanthin esters. Arch. Biochem. Biophys. 1995, 324, 385-390.